Background: Fluid overload is a major risk factor for mortality in patients undergoing peritoneal dialysis (PD). However, few studies have investigated the effect of chronic exposure to sustained fluid overload on long-term outcomes. Method: A total of 284 prevalent PD patients were included in this prospective study. Repeated multifrequency body composition analysis was performed 12 months apart, and 1-year cumulative chronic fluid overload were used to predict all-cause mortality and the risk for transfer to hemodialysis (HD) during the ensuing 15.6 ± 9.1 months. Results: The prevalence of fluid overload was approximately 27%. Interestingly, a substantial number of hypervolemic patients at first test were persistently hypervolemic at their second test. With this, chronic fluid overload was observed in 18.3% (n = 52). Notably, most of chronic fluid overload patients had diabetes (86.5%), and it was accompanied by concomitant changes in peritoneal membrane characteristics, a higher progression rate to high transporter. The risk of transfer to HD increased 2.8 times in patients with chronic fluid overload than in those without. Also, it significantly increased the risk of mortality (p = 0.038). Surprisingly, subgroup analysis found that patients with euvolemic status at follow-up experienced no mortality despite being in a fluid overload state at baseline. Conclusions: One-year chronic exposure to fluid overload is a strong independent risk factor for transfer to HD and death in prevalent PD patients. Although the fluid status of most PD patients is not easily changed over time, becoming euvolemic during the entire PD treatment period seems to be very important.

Keywords:
Peritoneal dialysis, Chronic fluid overload, Mortality, Technical failure, Bioimpedance test
1.
Siriopol D, Hogas S, Voroneanu L, et al: Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant 2013; 28: 2851–2859.
2.
O'Lone EL, Visser A, Finney H, et al: Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival. Nephrol Dial Transplant 2014; 29: 1430–1437.
3.
Guo Q, Yi C, Li J, et al: Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One 2013; 8:e53294.
4.
Chen W, Guo LJ, Wang T: Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients. Blood Purif 2007; 25: 260–266.
5.
Wang AY, Brimble KS, Brunier G, et al: ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part II – management of various cardiovascular complications. Perit Dial Int 2015; 35: 388–396.
6.
Zoccali C, Moissl U, Chazot C, et al: Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol 2017; 28: 2491–2497.
7.
Tzamaloukas AH, Saddler MC, Murata GH, et al: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6: 198–206.
8.
Wizemann V, Wabel P, Chamney P, et al: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574–1579.
9.
Luo YJ, Lu XH, Woods F, et al: Volume control in peritoneal dialysis patients guided by bioimpedance spectroscopy assessment. Blood Purif 2011; 31: 296–302.
10.
Dasgupta I, Farrington K, Davies SJ, et al: UK National survey of practice patterns of fluid volume management in haemodialysis patients: a need for evidence. Blood Purif 2016; 41: 324–331.
11.
John B, Tan BK, Dainty S, et al: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2010; 5: 1463–1470.
12.
Kim YL, Biesen WV: Fluid overload in peritoneal dialysis patients. Semin Nephrol 2017; 37: 43–53.
13.
Devolder I, Verleysen A, Vijt D, et al: Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010; 30: 208–214.
14.
Paniagua R, Amato D, Vonesh E, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307–1320.
15.
van Biesen W, Claes K, Covic A, et al: A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant 2013; 28: 2620–2628.
16.
Plum J, Schoenicke G, Kleophas W, et al: Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001; 16: 2378–2385.
17.
Van Biesen W, Williams JD, Covic AC, et al: Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 2011; 6:e17148.
18.
Ronco C, Verger C, Crepaldi C, et al: Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)†. Nephrol Dial Transplant 2015; 30: 849–858.
19.
Davison SN, Jhangri GS, Jindal K, et al: Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol 2009; 4: 1044–1050.
20.
Pletinck A, Verbeke F, Van Bortel L, et al: Acute central haemodynamic effects induced by intraperitoneal glucose instillation. Nephrol Dial Transplant 2008; 23: 4029–4035.
21.
Li PK, Culleton BF, Ariza A, et al: Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 2013; 24: 1889–1900.
22.
Pletinck A, Vanholder R, Veys N, et al: Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol 2012; 8: 542–550.
23.
Ketelhuth DF, Hansson GK: Adaptive response of T and B cells in atherosclerosis. Circ Res 2016; 118: 668–678.
24.
Davies SJ, Phillips L, Naish PF, et al: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046–1051.
25.
McCafferty K, Fan S, Davenport A: Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patients. Kidney Int 2014; 85: 151–157.
26.
Van Biesen W, Jorres A: Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating. Kidney Int 2014; 85: 15–17.
27.
Moissl U, Arias-Guillen M, Wabel P, et al: Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 2013; 8: 1575–1582.
28.
Onofriescu M, Hogas S, Voroneanu L, et al: Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 2014; 64: 111–118.
29.
Dong J, Xu Y, Li Y, et al: Does association with volume status and inflammation account for the increased death risk from high peritoneal protein clearance in peritoneal dialysis? Blood Purif 2010; 30: 127–134.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.